BioStem Technologies, Inc. (BSEM)
OTCMKTS · Delayed Price · Currency is USD
4.990
+0.070 (1.42%)
At close: Mar 26, 2026

BioStem Technologies Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
47.48301.8316.696.884.34
Revenue Growth (YoY)
-84.27%1708.93%142.69%58.38%1284.88%
Cost of Revenue
3.0413.751.260.881.47
Gross Profit
44.44288.0815.425.992.87
Selling, General & Admin
37.82254.7521.9110.214.07
Research & Development
7.091.910.340.220.12
Operating Expenses
45.13256.8822.4810.674.47
Operating Income
-0.6931.2-7.06-4.68-1.61
Interest Expense
--0.59-0.7-0.47-0.53
Interest & Investment Income
0.41----
Other Non Operating Income (Expenses)
-0.11--000.03
EBT Excluding Unusual Items
-0.3930.61-7.76-5.15-2.1
Gain (Loss) on Sale of Assets
----0.03
Legal Settlements
---0.72--
Other Unusual Items
----2.080.66
Pretax Income
-0.3930.61-8.48-7.23-1.41
Income Tax Expense
6.19-1.27---
Earnings From Continuing Operations
-6.5831.88-8.48-7.23-1.41
Minority Interest in Earnings
---0.04-0.03
Net Income
-6.5831.88-8.48-7.19-1.45
Net Income to Common
-6.5831.88-8.48-7.19-1.45
Shares Outstanding (Basic)
1716141112
Shares Outstanding (Diluted)
1722141112
Shares Change (YoY)
-22.90%58.30%20.18%-2.40%130.37%
EPS (Basic)
-0.391.95-0.62-0.63-0.12
EPS (Diluted)
-0.391.47-0.62-0.63-0.12
Free Cash Flow
---3.60.06-0.15
Free Cash Flow Per Share
---0.260.01-0.01
Gross Margin
93.59%95.45%92.44%87.17%66.03%
Operating Margin
-1.45%10.34%-42.30%-68.09%-36.99%
Profit Margin
-13.86%10.56%-50.84%-104.62%-33.30%
Free Cash Flow Margin
---21.60%0.87%-3.51%
EBITDA
-0.4631.41-6.83-4.46-1.32
EBITDA Margin
-0.97%10.41%-40.93%-64.86%-30.45%
D&A For EBITDA
0.230.210.230.220.28
EBIT
-0.6931.2-7.06-4.68-1.61
EBIT Margin
-1.45%10.34%-42.30%-68.09%-36.99%
Advertising Expenses
--0.20.090.07
Source: S&P Global Market Intelligence. Standard template. Financial Sources.